Subscribe to Search results

The post-mortem of a woman affected by transfusion-related jaundice returned a verdict of misadventure.

Published on:

Large pool plasma filtration was abandoned due to the prevalence of homologous serum jaundice.

Published on:

By 1975, two years after Hepatitis A was identified, there was a test for both Hepatitis A and Hepatitis B.

Published on:

US studies showed that serum hepatitis caused death at a rate of approximately 1 in every 150 transfusions in the US in people over the age of 40. US Studies showed the mortality rate in late middle age of those infected could be as high as 40%.

Published on:

Update on the expert groups ahead of the preliminary hearings

Published on:

Inquiry publishes report by the Statistics Expert Group

Published on:

Further instruction letter to Psychosocial expert group published

Published on:

"The Sunday Telegraph" reported that a post-mortem carried out on a man with haemophilia found the vCJD prion in his spleen, which prompted an update being urgently sent to people with bleeding disorders.

Published on:

The chief medical officers of each of the four nations responded to a request to approve the framework for the management of possible exposures to CJD through medical procedures.

Published on:

A fourth case of vCJD transmission was associated with blood transfusion and was reported to the press.

Published on:

It was confirmed that a post-mortem carried out on a man with haemophilia found the vCJD prion in his spleen. He did not die of vCJD; nor was it present in the brain. The probability was that he had been infected and that the likeliest cause was his treatment with plasma product.

Published on:

The CJD Incidents Panel wrote to those responsible for tracing vCJD-implicated plasma batches setting out tables of implicated batch numbers.

Published on:

A second case of transfusion-related vCJD was reported in July 2004.

Published on:

People with a bleeding disorder were informed by their haemophilia centre and given an opportunity to discuss the implications and to find out if they had received an implicated batch if they wished.

Published on:

Alan Milburn, Secretary of State for Health, announced further details of the compensation scheme.

Published on:

From the end of 1999, no UK plasma was used.

Published on:

The MSBT discussed how to manage donors known to have received blood from people who subsequently developed vCJD. The outcome was reported to Dr Angela Robinson in her role as medical director of the National Blood Authority.

Published on:

The Chief Medical Officer issued a statement which reported that three patients who had suffered from vCJD had been blood donors, and a fourth was suspected of having been one too.

Published on:

The Lothian Ethics Committee initially took the view that no attempt should be made to trace nor inform recipients of implicated donations, and after being asked to review its position in October 1997, reiterated its earlier advice.

Published on:

Dr Patricia Hewitt spoke informally to Professor Ian Kennedy regarding a study to check on recipients of those blood donors who later developed vCJD.

Published on: